{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:13:39Z","timestamp":1792700019432,"version":"4.5.0"},"reference-count":57,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"United Arab Emirates University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is linked with unusual differentiation and hyperproliferation of epidermal keratinocytes that significantly impair the quality of life (QoL) of patients. The present treatment options only provide symptomatic relief and are surrounded by various adverse effects. Recently, nanostructured lipid carriers (NLCs) have emerged as next-generation nanocarriers with better physicochemical characteristics. The current manuscript provides background information on psoriasis, its pathophysiology, existing treatment options, and its limitations. It highlights the advantages, rationale, and mechanism of the permeation of NLCs for the treatment of psoriasis. It further gives a detailed account of various NLC nanoformulations for the treatment of psoriasis. In addition, tabular information is provided on the most relevant patents on NLCs for treating psoriasis. Lastly, light is shed on regulatory considerations related to NLC-like nanoformulations. In the treatment of psoriasis, NLCs display a sustained release drug profile, an ability to incorporate both hydrophobic and hydrophilic drugs, an enhancement in skin hydration, penetrability, retention, and bioavailability of the drug, along with reduced staining potential as compared to conventional ointments, and decreased side effects of drug molecules. This affirms the bright future of NLC nanoformulations in the treatment of psoriasis. However, academic industry collaboration and more sound regulatory controls are required to commercialize the NLC nanoformulations for psoriasis treatment.<\/jats:p>","DOI":"10.3390\/ijms24032978","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T03:04:23Z","timestamp":1675393463000},"page":"2978","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3323-6637","authenticated-orcid":false,"given":"Tulshidas S.","family":"Patil","sequence":"first","affiliation":[{"name":"Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule 424001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayan A.","family":"Gujarathi","sequence":"additional","affiliation":[{"name":"Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule 424001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5287-3001","authenticated-orcid":false,"given":"Abhijeet A.","family":"Aher","sequence":"additional","affiliation":[{"name":"Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule 424001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemal E.","family":"Pachpande","sequence":"additional","affiliation":[{"name":"Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule 424001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-2966","authenticated-orcid":false,"given":"Shreesh","family":"Ojha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain P.O. Box 15551, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-7049","authenticated-orcid":false,"given":"Sameer N.","family":"Goyal","sequence":"additional","affiliation":[{"name":"Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule 424001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-5607","authenticated-orcid":false,"given":"Yogeeta O.","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Shri Vile Parle Kelavani Mandal\u2019s Institute of Pharmacy, Dhule 424001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023, January 20). Global Report on Psoriasis 2016. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/204417."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/ijmr.IJMR_1296_17","article-title":"Research on psoriasis in India: Where do we stand?","volume":"146","author":"Thappa","year":"2017","journal-title":"Indian J. Med. Res"},{"key":"ref_3","unstructured":"Ferreira, M. (2015). Nanostructured Lipid Carriers: A New Approach for Psoriasis Dermal Therapy. [Master\u2019s Thesis, University of Porto]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.colsurfb.2019.05.074","article-title":"Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice","volume":"181","author":"Ghate","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105438","DOI":"10.1016\/j.ejps.2020.105438","article-title":"Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: Optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition","volume":"152","author":"Rapalli","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0378-6323.115505","article-title":"Pathophysiology of psoriasis","volume":"79","author":"Mahajan","year":"2013","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_7","first-page":"6","article-title":"Update on the pathophysiology of psoriasis","volume":"102","author":"Hugh","year":"2018","journal-title":"Cutis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1346-8138.15913","article-title":"Pathophysiology of psoriasis: A review","volume":"48","author":"Yamanaka","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: Keratinocytes or immune cells\u2014which is the trigger?","volume":"235","author":"Benhadou","year":"2019","journal-title":"Dermatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_11","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim","year":"2017","journal-title":"Can. Fam. Physician."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4103\/idoj.IDOJ_113_21","article-title":"Systemic management of psoriasis patients in Indian scenario: An expert consensus","volume":"12","author":"Rajagopalan","year":"2021","journal-title":"Indian Dermatol. Online J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of psoriasis and development of treatment","volume":"45","author":"Ogawa","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"key":"ref_15","first-page":"344","article-title":"Use of retinoids in the treatment of psoriasis","volume":"8","author":"Warren","year":"1989","journal-title":"Clin. Pharm."},{"key":"ref_16","unstructured":"American Academy of Dermatology Association (2023, January 20). Psoriasis Treatment: Coal Tar. Available online: https:\/\/www.aad.org\/public\/diseases\/psoriasis\/treatment\/medications\/coal-tar."},{"key":"ref_17","unstructured":"Aronson, J.K. (2016). Meyler\u2019s Side Effects of Drugs, The International Encyclopedia of Adverse Drug Reactions and Interactions, Elsevier. [16th ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.steroids.2015.05.012","article-title":"Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"101","author":"Pradhan","year":"2015","journal-title":"Steroids"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2010.09.007","article-title":"Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"401","author":"Agrawal","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.2147\/IJN.S247007","article-title":"Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: Formulation, optimization, characterization, in-vitro and in-vivo studies","volume":"15","author":"Agrawal","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1517\/17425247.2015.982088","article-title":"Nanomedicine-based drug targeting for psoriasis: Potentials and emerging trends in nanoscale pharmacotherapy","volume":"12","author":"Rahman","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425247.2012.666967","article-title":"Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals","volume":"9","author":"Puglia","year":"2012","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"29080","DOI":"10.1039\/D1RA06087B","article-title":"Lipid-based nanoparticles for psoriasis treatment: A review on conventional treatments, recent works, and future prospects","volume":"11","author":"Nordin","year":"2021","journal-title":"RSC Adv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"Muller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34172\/apb.2020.021","article-title":"Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery","volume":"10","author":"Chauhan","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for pulmonary application: A review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2018.05.070","article-title":"Nanostructured lipid carriers-based drug delivery for treating various lung diseases: A state-of-the-art review","volume":"547","author":"Patil","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/1061186X.2018.1455842","article-title":"Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: Current status and futuristic need","volume":"27","author":"Patil","year":"2019","journal-title":"J. Drug Target"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/21691401.2013.832683","article-title":"Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis","volume":"43","author":"Agrawal","year":"2015","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17425247.2017.1264386","article-title":"Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: A comparative study","volume":"14","author":"Arora","year":"2017","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijpharm.2014.10.067","article-title":"A new topical formulation for psoriasis: Development of methotrexate-loaded nanostructured lipid carriers","volume":"477","author":"Pinto","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jconrel.2005.09.045","article-title":"Lipid nanoparticles for skin penetration enhancement\u2014Correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy","volume":"110","author":"Borgia","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2012.06.021","article-title":"Development of paclitaxel-TyroSpheres for topical skin treatment","volume":"63","author":"Kilfoyle","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_34","first-page":"117","article-title":"Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery","volume":"5","author":"Lin","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jps.21817","article-title":"Penetration of nanoparticles and nanomaterials in the skin: Fiction or reality?","volume":"99","author":"Baroli","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1166\/jbn.2007.049","article-title":"Lipid nanoparticles (SLN\u00ae, NLC\u00ae) for cutaneous drug delivery: Structure, protection and skin effects","volume":"3","author":"Souto","year":"2007","journal-title":"J. Biomed. Nanotech."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2013.08.019","article-title":"Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity","volume":"456","author":"Raza","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13370","DOI":"10.1111\/dth.13370","article-title":"Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast","volume":"33","author":"Madan","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.ijbiomac.2018.08.136","article-title":"Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis","volume":"120","author":"Tripathi","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s13346-020-00723-6","article-title":"Nanostructured lipid carrier co-delivering tacrolimus and TNF-\u03b1 siRNA as an innovate approach to psoriasis","volume":"10","author":"Viegas","year":"2020","journal-title":"Drug Deliv. Trans. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3109\/10837450.2015.1026605","article-title":"A novel nanogel formulation of methotrexate for topical treatment of psoriasis: Optimization, in vitro and in vivo evaluation","volume":"21","author":"Avasatthi","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/03639045.2020.1793998","article-title":"Systematic development and characterization of curcumin-loaded nanogel for topical application","volume":"46","author":"Kesharwani","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/03639045.2019.1576722","article-title":"Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model","volume":"45","author":"Sathe","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.biomaterials.2018.08.030","article-title":"Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice","volume":"182","author":"Kang","year":"2018","journal-title":"Biomaterials"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"118487","DOI":"10.1016\/j.ijpharm.2019.118487","article-title":"The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin","volume":"567","author":"Cordenonsi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/2211738506666180523112513","article-title":"Topical nanostructured lipid carrier based hydrogel of mometasone furoate for the treatment of psoriasis","volume":"6","author":"Kaur","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"ref_47","unstructured":"Pradhan, M., Sahu, K., Singh, D., Singh, M., and Yadav, K. (2021). A Method of Preparation of Triamcinolone Acetonide Encapsulated Nanostructured Lipid Carriers for Psoriasis Treatment. (AU2021106678)."},{"key":"ref_48","unstructured":"Parmar, M., Patel, L., Rathod, L., and Parikh, K. (2020). Nanostructured Lipid Carriers Containing Tazarotene and Pharmaceutical Formulations Containing Said Particles. (IN201921023616)."},{"key":"ref_49","unstructured":"Kudamala, R., Suggala, V., Veeram, J., and Palagati, S. (2021). Antipsoriatic Effects of Clobetasol Loaded Nanostructured Lipid Carriers on Imiquimod Induced Psoriasis. (IN202141009486)."},{"key":"ref_50","unstructured":"Kudamala, R., Shaik, C., Veeram, J., Medarametla, K., Anna, B., Chiruthanur, M.C.G., Ponnaiah, B., Ranganatham, V., and Palagati, S. (2021). Clobetasol Loaded Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Treatment of Psoriasis. (IN202141046636)."},{"key":"ref_51","unstructured":"Shah, M., Panigrahi, L., Patravale, V., and Kakade, P. (2020). Topical Composition. (IN201921019828)."},{"key":"ref_52","unstructured":"Yan, C., Zhenhai, Z., Zhou, L., and Qingqing, W. (2013). Tripterine Nanostructure Lipid Carrier and Preparation Method and Application Thereof. (CN102225205B)."},{"key":"ref_53","unstructured":"Sachdeva, M., and Patlolla, R. (2014). Novel Nanoparticle Formulations for Skin Delivery. (US20120195957A1)."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1039\/D0BM00558D","article-title":"The regulation of nanomaterials and nanomedicines for clinical application: Current and future perspectives","volume":"8","author":"Foulkes","year":"2020","journal-title":"Biomater. Sci."},{"key":"ref_55","unstructured":"(2023, January 20). Guidelines for Evaluation of Nanopharmaceuticals in India, Available online: https:\/\/dbtindia.gov.in\/sites\/default\/files\/uploadfiles\/Guidelines_For_Evaluation_of_Nanopharmaceuticals_in_India_24.10.19.pdf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1515\/ntrev-2022-0109","article-title":"Nanostructured Lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery","volume":"11","author":"Javed","year":"2022","journal-title":"Nanotechnol. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157016311796799062","article-title":"20 years of lipid nanoparticles (SLN&NLC): Present state of development&industrial applications","volume":"8","author":"Muller","year":"2011","journal-title":"Curr. Drug Discov. Technol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2978\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:23:09Z","timestamp":1760120589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032978"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032978","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}